‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
JAMA Editors' Summary
Blinatumomab for B-cell ALL Relapse, IVIG for MIS-C, Review of Irritable Bowel Syndrome, and more
30
00:00:00
/ 00:10:38
30